Literature DB >> 21607641

Neurosurgical treatment of tuberous sclerosis complex lesions.

Ignacio Pascual-Castroviejo1.   

Abstract

BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominantly inherited syndrome. Renal disease is the main cause of death. Brain disorders are the origin of more frequent and severe problems, such as tumors, epilepsy, and mental retardation. Participation of neurosurgeons in the study and especially in the treatment of TSC patients is often required.
MATERIALS AND METHODS: Two types of pathological conditions mainly require neurosurgical interventions in TSC: subependymal giant cell astrocytomas (SGCA) and cortical tubers. SGCA are located in the cerebral region close to the foramina of Monroe, uni- or bilaterally, and originate in hamartomas that can grow slowly as well as rapidly, even suddenly, especially in cases with intratumoral cyst, causing increased intracranial pressure (ICP) with severe risk for visual loss and life. Neurosurgeons have to participate in the follow-up of the patients as soon as the risk of ICP exists to remove the tumor when the criteria of SGCA growth are present. The other intracranial lesions that require neurosurgical intervention by are the cortical tubers.
CONCLUSION: These dysplastic lesions are associated with TSC in almost the 100% of affected persons and are the cause of epilepsy in most patients. The seizures can be resistant to antiepileptic medication in many cases in which a tuber is identified as the origin of the focal seizures after functional studies, such as EEG, MR, PET, etc. In these cases, only surgical removal of the tuber and the perituberal epileptogenic foci can cure the epilepsy. Large tubers are more epileptogenic than smaller ones.

Entities:  

Mesh:

Year:  2011        PMID: 21607641     DOI: 10.1007/s00381-011-1488-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  67 in total

1.  Cerebellar abnormality in children and young adults with tuberous sclerosis complex: MR and diffusion weighted imaging findings.

Authors:  G Ertan; S Arulrajah; A Tekes; L Jordan; T A G M Huisman
Journal:  J Neuroradiol       Date:  2010-04-08       Impact factor: 3.447

Review 2.  Neonatal subependymal giant cell astrocytoma: new case and review of literature.

Authors:  G Praveen Raju; David K Urion; Mustafa Sahin
Journal:  Pediatr Neurol       Date:  2007-02       Impact factor: 3.372

3.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

4.  Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex.

Authors:  Ala Birca; Claude Mercier; Philippe Major
Journal:  J Neurosurg Pediatr       Date:  2010-10       Impact factor: 2.375

5.  On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis.

Authors:  C Di Rocco; A Iannelli; E Marchese
Journal:  Pediatr Neurosurg       Date:  1995       Impact factor: 1.162

Review 6.  Infantile spasms in tuberous sclerosis complex.

Authors:  P Curatolo; S Seri; M Verdecchia; R Bombardieri
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

7.  [Subependymal nodules-sudependymal giant cell astrocytoma complex in children with tuberous sclerosis].

Authors:  Lucas Bongiorni; Hugo A Arroyo; Fabiana Lubienicki
Journal:  Medicina (B Aires)       Date:  2009       Impact factor: 0.653

8.  Localization of epileptic foci in children with intractable epilepsy secondary to multiple cortical tubers by using synthetic aperture magnetometry kurtosis.

Authors:  Ichiro Sugiyama; Katsumi Imai; Yu Yamaguchi; Ayako Ochi; Yoko Akizuki; Cristina Go; Tomoyuki Akiyama; O Carter Snead; James T Rutka; James M Drake; Elysa Widjaja; Sylvester H Chuang; Doug Cheyne; Hiroshi Otsubo
Journal:  J Neurosurg Pediatr       Date:  2009-12       Impact factor: 2.375

9.  TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1/ TSC2 frequency ratios.

Authors:  Nicola Langkau; Nicola Martin; Regine Brandt; Karin Zügge; Stefanie Quast; Gerd Wiegele; Anna Jauch; Marion Rehm; Andrea Kuhl; Monika Mack-Vetter; Lothar Bernd Zimmerhackl; Bart Janssen
Journal:  Eur J Pediatr       Date:  2002-06-08       Impact factor: 3.183

10.  Epilepsy surgery in tuberous sclerosis: the Dutch experience.

Authors:  F E Jansen; A C Van Huffelen; P C Van Rijen; F S S Leijten; A Jennekens-Schinkel; P Gosselaar; O Van Nieuwenhuizen
Journal:  Seizure       Date:  2007-04-06       Impact factor: 3.184

View more
  5 in total

1.  Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.

Authors:  Flavio Giordano; Carla Moscheo; Matteo Lenge; Roberto Biagiotti; Francesco Mari; Iacopo Sardi; Anna Maria Buccoliero; Lorenzo Mongardi; Eleonora Aronica; Renzo Guerrini; Lorenzo Genitori
Journal:  Childs Nerv Syst       Date:  2019-12-18       Impact factor: 1.475

Review 2.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

3.  Resection of subependymal giant cell astrocytoma guided by intraoperative magnetic resonance imaging and neuronavigation.

Authors:  Hecheng Ren; Xiaolei Chen; Guochen Sun; Shen Hu; Gang Zheng; Fangye Li; Jinjiang Li; Bainan Xu
Journal:  Childs Nerv Syst       Date:  2013-02-10       Impact factor: 1.475

4.  Rapamycin therapy for neonatal tuberous sclerosis complex with cardiac rhabdomyomas: A case report and review.

Authors:  Shanshan Mao; Qi Long; Huijia Lin; Jinling Liu
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

5.  Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.

Authors:  Katarzyna Kotulska; Julita Borkowska; Marek Mandera; Marcin Roszkowski; Elzbieta Jurkiewicz; Wiesława Grajkowska; Małgorzata Bilska; Sergiusz Jóźwiak
Journal:  Childs Nerv Syst       Date:  2014-09-17       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.